Evidence map›Paper›PMID 33564318›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Protective Effects of Shenfuyixin Granule on H

Xinlu Wang, Xuanxuan Hao, Youping Wang, Bin Li, Lin Cui, Shiyang Xie, Yongxia Wang, Mingjun Zhu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xinlu WangThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.ORCID https://orcid.org/0000-0002-2875-4125
Xuanxuan HaoHenan University of Chinese Medicine, Zhengzhou, Henan, China.
Youping WangThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Bin LiThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Lin CuiThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Shiyang XieThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Yongxia WangThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.
Mingjun ZhuThe First Affiliated Hospital of Henan University of CM, Zhengzhou, Henan, China.ORCID https://orcid.org/0000-0001-7646-6577
First Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shenfuyixin granule (SFYXG, i.e., Xinshuaikang granule) is a prescription, commonly used in the clinical experience, which plays a significant role in the treatment of heart failure. The purpose of this present research was to investigate the protective effect of SFYXG, and the mechanism about anti-H

Identifiers

PMID33564318
PMCPMC7867454
OpenAlexW3128960919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.